#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Philadelphia positive acute lymphocytic leukaemia Retinal dystrophy Pneumonia Henoch-Schonlein purpura Biliary neoplasm Renal disorder Autoimmune haemolytic anaemia Philadelphia chromosome positive Adenocarcinoma pancreas Adrenoleukodystrophy Pleomorphic leiomyosarcoma Pyruvate kinase deficiency anaemia Ovarian cancer stage IV Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Life with Disease Krabbe’s disease – Treatment Lymphangioma – Treatment Mastocytosis – Diagnostics Toxic epidermal necrolysis – Treatment Epidermolysis bullosa – Trials in Disease Idiopathic pulmonary fibrosis – Treatment Fragile X syndrome – Life with Disease Noonan syndrome – Diagnostics Langerhans’ cell histiocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Messenger Rna Encoding Cas9 Elraglusib Ddcart‐Cd19 Emtricitabine Goserelin Acetate TIFCEMALIMAB BENZYLPENICILLIN POTASSIUM Avelumab Carbasalate Calcium Ruzasvir Lenacapavir Sodium Mycophenolate Mofetil Salbutamol Sulfate Ph. Eur. Chloride Ion PICLIDENOSON Venglustat Sodium Thiosulfate Zofenopril Calcium Bosutinib Dazodalibep More therapies…

    Learn about Your Condition

    Myeloid leukaemia Immune-mediated renal disorder Glomerulonephritis chronic Mucosal inflammation Wolfram syndrome Hyperinsulinism Neuropathy peripheral Hepatobiliary disease Latent tuberculosis Poor quality sleep Sarcoidosis Tumour of ampulla of Vater Injury Altered state of consciousness Barrett's oesophagus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Headache Effects of Sildenafil and Placebo in Men and Women with Episodic Migraine Without Aura

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Migraine without aura
    Investigated Drugs:
    • Sildenafil
    • Ibuprofen
    • Sumatriptan Succinate
    Denmark
  • Study on the Safety and Effects of LY3884963 for Patients with Fronto-Temporal Dementia with Progranulin Mutations

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Expressing Codon-Optimized Human Grn Gene
    • Methylprednisolone
    • Prednisone
    Belgium France
  • Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    • Primary progressive multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    • Rituximab
    Denmark
  • Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • CDKL5 deficiency disorder
    Investigated Drugs:
    • Fenfluramine Hydrochloride
    Austria Belgium Germany Ireland Italy The Netherlands +2
  • Study on the Effectiveness and Safety of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Losmapimod
    Denmark France Germany Italy The Netherlands Spain
  • Study on Repeated Corticosteroid Injections with Methylprednisolone Acetate and Sodium Chloride for Patients with Chronic Cluster Headache

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Methylprednisolone Acetate
    • Sodium Chloride
    The Netherlands
Previous Page
1 … 98 99 100 101 102 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!